← Leaderboards
Daniel S Warren
Johns Hopkins University
$1,700,187
Attributed
$2,599,712
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $970.3K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,599,712 · 3
By mechanism
R01$2,409,104 · 2
P50$190,608 · 1
Top collaborators
- Harry C. Dietz5 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Harry C. Dietz$10,377,475
- Dorry Segev$40,743,790
- Christine Marie Durand$23,429,807
- Chirag R Parikh$38,095,595
- Andrew M Cameron$6,342,614
Others in their field
Top investigators on “Pathology”
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Paul S. Aisen · Cognition Therapeutics, Inc.$155,099,919
- Reisa A. Sperling · Banner Health$154,825,070
- Ronald T Mitsuyasu · University Of California Los Angeles$145,092,412
- Joseph E Robertson · Oregon Health & Science University$126,125,279
Research focus
PathologyPathogenesisTissuesInvestigationPharmacologyEventOrganPathogenicityPerformanceProbabilityCollagenAutoantibodiesCicatrixAutoimmune DiseasesAntimicrobial PeptideAdaptive ImmunityDendritic Cell ActivationCell SurfaceBindingCellsAntibodiesBlocking AntibodiesB-LymphocytesCell Type
Grant awards (8)
Administrative Core$97,515
P50 · FY2025 · AA · contact PI
Administrative Core$93,093
P50 · FY2024 · AA · contact PI
Mechanistic and Therapeutic Investigations of Scleroderma$360,250
R01 · FY2020 · AR
Reducing geographic disparities in kidney and liver allocation$610,054
R01 · FY2019 · DK · contact PI
Mechanistic and Therapeutic Investigations of Scleroderma$360,250
R01 · FY2019 · AR
Mechanistic and Therapeutic Investigations of Scleroderma$360,250
R01 · FY2018 · AR
Mechanistic and Therapeutic Investigations of Scleroderma$359,700
R01 · FY2017 · AR
Mechanistic and Therapeutic Investigations of Scleroderma$358,600
R01 · FY2016 · AR